Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07222709
PHASE1

A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

This study will assess the adverse events, tolerability, and how oral ascending doses of ABBV-1042 moves through the body of healthy adult participants.

Official title: A Phase 1, Double-blind, Placebo-controlled, First-in-human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ABBV-1042 in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-10-27

Completion Date

2026-05

Last Updated

2025-10-30

Healthy Volunteers

Yes

Interventions

DRUG

ABBV-1042

Oral Solution

DRUG

Placebo

Oral Solution

Locations (1)

Acpru /Id# 279405

Grayslake, Illinois, United States